30 studies found for:    weill AND injection medications | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Essential Voice Tremor: A Study of Botulinum Toxin Treatment and Injection Augmentation
Condition: Essential Tremor
Interventions: Drug: RenuGel;   Drug: Botulinum Toxin
2 Recruiting Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
Condition: Brain Tumors With Ill-defined Margins
Intervention: Drug: Indigo carmine
3 Recruiting BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors
Conditions: Metastatic Cancer;   Cancer;   Solid Tumor
Interventions: Drug: BP31510 monotherapy;   Drug: BP31510 in combination with chemotherapy
4 Recruiting Intra-arterial Chemotherapy for Spinal Metastases
Conditions: Spinal Diseases;   Spinal Metastases;   Spinal Tumors
Intervention: Drug: Melphalan (intra-arterial infusion)
5 Recruiting Gamete Treatment to Correct Fertilization Failure
Condition: Infertility
Intervention: Procedure: gamete treatment
6 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy
7 Available EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML
Condition: Secondary AML
Intervention: Drug: CPX-351
8 Recruiting 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Drug: 89Zr-J591;   Device: PET/CT Scan;   Device: MRI;   Other: Blood draw
9 Recruiting RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
Conditions: Breast Cancer;   Infertility
Intervention: Drug: Letrozole
10 Recruiting Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With and Without Peripheral Arterial Disease
Conditions: Peripheral Arterial Disease;   Diabetic Foot
Interventions: Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
11 Recruiting Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Conditions: Chronic Pain;   Osteoarthritis, Hip;   Osteoarthritis, Knee
Interventions: Drug: NSAID;   Biological: Tanezumab 2.5 mg;   Biological: Tanezumab 5 mg
12 Recruiting Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
Conditions: Brain Cancer;   Brain Neoplasm;   Glioma;   Glioblastoma;   Gliosarcoma;   Malignant Brain Tumor;   Neoplasm, Neuroepithelial;   Neuroectodermal Tumors;   Neoplasm by Histologic Type;   Neoplasm, Nerve Tissue;   Nervous System Diseases
Interventions: Biological: DNX-2401;   Biological: pembrolizumab
13 Recruiting Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection
Conditions: HIV-1 Infection;   Hepatitis
Interventions: Drug: Ribavirin;   Drug: Sofosbuvir;   Drug: Ledipasvir/Sofosbuvir
14 Not yet recruiting PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
Condition: Osteoporotic Fractures
Interventions: Drug: Teriparatide Prefilled Syringe;   Drug: Placebo
15 Recruiting Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: 99mTc-MIP-1404 Injection
16 Recruiting Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: abicipar pegol;   Drug: ranibizumab;   Other: sham procedure
17 Recruiting Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer
Conditions: Metastatic Prostate Cancer;   Pain
Intervention: Drug: Radium-223
18 Recruiting Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ H2N- Advanced Breast Cancer
Conditions: Metastatic Breast Cancer;   Breast Carcinoma
Interventions: Drug: LEE-011;   Drug: Fulvestrant;   Drug: Placebo
19 Recruiting P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Biological: Toca 511;   Drug: Toca FC;   Drug: Lomustine;   Drug: Temozolomide;   Biological: Bevacizumab
20 Recruiting Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
Conditions: Lymphoma, Extranodal NK-T-Cell;   EBV
Intervention: Biological: CMD-003

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.